Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects

Endocrine Journal

Volumn 55, Issue 5, 2008, Pages 811-818

  Lee, Ji Won ^a   Lee, Hye Ree ^a   Shim, Jae Yong ^a   Im, Jee Aee ^b   Lee, Duk Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b MizMedi Hospital   (South Korea)

Author keywords

Fat distribution; Nondiabetic; Retinol binding protein 4; Visceral fat; Weight reduction

Indexed keywords

RETINOL BINDING PROTEIN 4;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HEALTH PROGRAM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSITY; ADULT; APPETITE DEPRESSANTS; CYCLOBUTANES; DIET, REDUCING; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; RETINOL-BINDING PROTEINS, PLASMA; WEIGHT LOSS; YOUNG ADULT;

EID: 55049118712     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-030     Document Type: Article

References (26)

1. Fruhbeck G (2004) The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2: 197-208.
2. Katagiri H, Yamada T, Oka Y (2007) Adiposity and cardiovascular disorders : disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101: 27-39.
3. Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J 18: 4633-4644.
4. Hong CY, Chia KS (1998) Markers of diabetic nephropathy. J Diabetes Complications 12: 43-60.
5. Tamori Y, Sakaue H, Kasuga M (2006) RBP4, an unexpected adipokine. Nat Med 12: 30-1; discussion 31.
6. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436: 356-362.
7. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354: 2552-2563.
8. Vitkova M, Klimcakova E, Kovacikova M, Valle C, Moro C, Polak J, Hanacek J, Capel F, Viguerie N, Richterova B, Bajzova M, Hejnova J, Stich V, Langin D (2007) Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J Clin Endocrinol Metab 92: 2330-2335.
9. Takashima N, Tomoike H, Iwai N (2006) Retinol-binding protein 4 and insulin resistance. N Engl J Med 355: 1392, author reply 1394-1395.
10. Erikstrup C, Mortensen OH, Pedersen BK (2006) Retinol-binding protein 4 and insulin resistance. N Engl J Med 355: 1393-1394, author reply 1394-1395.
11. Janke J, Engeli S, Boschmann M, Adams F, Bohnke J, Luft FC, Sharma AM, Jordan J (2006) Retinol-binding protein 4 in human obesity. Diabetes 55: 2805-2810.
12. Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92: 2590-2597.
13. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
14. A. Friedewald WT, Levy RI, Fridrikson DS (1972) Estimation of concentrations of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502.
15. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T (2007) Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 92: 2712-2719.
16. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74: 761-811.
17. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A (2006) Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49: 744-747.
18. Matsuzawa Y (2006) The metabolic syndrome and adipocytokines. FEBS Lett 580: 2917-2921.
19. Haider DG, Schindler K, Prager G, Bohdjalian A, Luger A, Wolzt M, Ludvik B (2007) Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab 92: 1168-1171.
20. Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, Xiang K (2007) Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and without Type 2 Diabetes. J Clin Endocrinol Metab 92: 3224-3229.
21. Lee JW, Im JA, Lee HR Shim JY, Youn BS, Lee DC (2007) Visceral Adiposity Is Associated with Serum Retinol Binding Protein-4 Levels in Healthy Women. Obesity 15: 2225-2232.
22. Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, Schon MR, Stumvoll M, Bluher M, Kahn B (2007) Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 6: 79-87.
23. Schindler K, Haider D, Wolzt M, Rieger A, Gmeinhart B, Luger A, Nowotny P, Ludvik B (2006) Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur J Clin Invest 36: 640-646.
24. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D (2007) Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 92: 1971-1974.
25. Blaner WS (1989) Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 10: 308-316.
26. Yki-Jarvinen H, Westerbacka J (2005) The fatty liver and insulin resistance. Curr Mol Med 5: 287-295.